Format

Send to

Choose Destination
Sci Rep. 2015 Nov 24;5:17091. doi: 10.1038/srep17091.

Meta-analysis of colistin for the treatment of Acinetobacter baumannii infection.

Author information

1
Department of Hospital Infection-Control, Affiliated Houjie Hospital, Guangdong Medical College, Dongguan, Guangdong 523945, China.
2
Department of Urology, Affiliated Hospital of Huzhou Teachers' College, The First People's Hospital of Hu zhou, Hu zhou, 313000, P.R. China.
3
Department of Joint Surgery, Chenzhou NO.1 People's Hospital, Hunan Province, 423000 P.R. China.

Abstract

Multidrug resistant among Acinetobacter baumannii infection is associated with a high mortality rate and limits the therapeutic options. The aim of this study was to assess the safety and efficacy of colistin monotherapy vs. other single antibiotic therapy AND colistin-based combination therapy (with other antibiotics) vs. colistin alone for the treatment of Acinetobacter baumannii infection. Online electronic database were searched for studies evaluating colistin with or without other antibiotics in treatment of patients with drug-resistant Acinetobacter baumannii infection. Totally, twelve studies met the inclusion criteria. For colistin-based combination therapy, six articles including 668 patients were included. Our results showed that the overall clinical response did not differ significantly between colistin-based combination therapy and monotherapy (OR = 1.37, 95% CI = 0.86-2.19, P = 0.18). This insignificance was also detected in ICU mortality, length of stay and nephrotoxicity (P > 0.05). However, the colistin-based combination therapy was shown increasing the microbiological response (OR = 2.14, 95% CI = 1.48-3.07, P < 0.0001). For colistin monotherapy, six studies involving 491 patients were analyzed. The results were in concordance with the findings of the colistin-based combination therapy group. Our results suggest that colistin may be a promising therapy as safe and efficacious as standard antibiotics for the treatment of drug-resistant Acinetobacter baumannii infection.

PMID:
26597507
PMCID:
PMC4657015
DOI:
10.1038/srep17091
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center